Citi Reaffirms Bullish Outlook on Nova Measuring Instruments (NVMI)
On June 3, Citi analysts reiterated a 'Buy' rating and a $280 price target on Nova Measuring Instruments (NASDAQ:NVMI) stock.
Insider Monkey Blog
Stifel Maintains Buy Rating on Nurix (NRIX) Stock
On June 3, Stifel Nicolaus analyst Stephen Willey maintained a Buy rating on Nurix Therapeutics, Inc. (NASDAQ:NRIX) with a price target of $35.
Barclays Lowers Becton, Dickinson & Co. (BDX) Price Target, Maintains Overweight Rating
On June 3, Matt Miksic from Barclays lowered the price target on Becton, Dickinson, and Company (NYSE:BDX) from $261 to $241, while keeping an Overweight rating on the shares.
10 AI Stocks on Wall Street’s Radar
Big tech giants had a blockbuster quarter recently, and the momentum seemingly remains strong amongst chip makers and AI developers.
Rio Tinto Group (RIO) Downgraded at Jefferies
In a research note, the analyst informs investors that the company's strategic path is uncertain due to the news that Jakob Stausholm will be leaving his position as CEO of Rio...
Blueprint Medicines Corporation (BPMC) Downgraded at TD Cowen
This modification comes after Sanofi declared its intention to buy Blueprint Medicines Corporation (NASDAQ:BPMC).
MAC Copper Limited (MTAL) Downgraded at BMO Capital
This happened as a result of MAC Copper Limited (NYSE:MTAL) signing a legally binding contract with Harmony Gold Mining Company and Harmony Gold Australia, which calls for Harmony...
As Korea Explores Monetary-Sovereign Stablecoins, Ruble-Pegged A7A5 in Kyrgyzstan Completes Public Audit
South Korea is actively laying the groundwork for its digital currency future.
Meta Platforms, Inc. (META) Strikes Nuclear Power Deal with Constellation Energy Corporation (CEG)
The move comes amid a growing wave of Big Tech companies teaming up with the industry to secure electricity as power demand in the United States rises for the first time in two...
EVgo, Inc. (EVGO) Initiated with a Neutral View at Morgan Stanley
[caption id="attachment_1208988" align="aligncenter" width="1456"] A businessman plugging in to a public charging station, symbolizing the services provided by the company.[/caption...
Wolfe Research Lowered Blueprint Medicines Corporation (BPMC) from Outperform to Peer Perform
This happened after Sanofi announced plans to buy the company for $9.1 billion in stock value and up to $9.5 billion in contingent value rights.
Citi Cuts The Campbell’s Company (CPB)’s Price Target by $1
[caption id="attachment_1202280" align="aligncenter" width="1456"] A woman preparing a meal using packaged foods with V8 juices and the other products of the company in the background...
Oppenheimer Raises Price Target for Trevi Therapeutics by $3
In a research note, the analyst informs investors that Haduvio's favorable topline Phase 2b news strengthens the company's case for addressing idiopathic pulmonary fibrosis persistent...
Hedge Fund and Insider Trading News: John Paulson, Ray Dalio, Bill Ackman, Ken Griffin, Arrowpoint Investment Partners, Bridgewater Associates, Wex Inc (WEX), MicroStrategy Inc (MSTR), and More
You may be concerned about the recent declines in AI stocks such as NVDA.
Ingersoll Rand Inc. (IR) Acquires Lead Fluid to Strengthen Life Sciences Growth in Key Regions
Lead Fluid, based in China, specializes in high-precision fluid-handling equipment, such as peristaltic, syringe, and gear pumps, used in life sciences where accurate fluid control...
Zscaler, Inc. (ZS) Unveils AI Tools to Boost Security and Enable Safe AI Use
Zscaler, Inc. (NASDAQ:ZS) announced new AI-driven security features today aimed at strengthening data protection and preventing cyberattacks.
Hims & Hers Health, Inc. (HIMS) to Buy European Telehealth Firm as Part of Global Growth Strategy
The company stated that the deal is expected to be finalized by mid-year.
Wells Fargo Lifts CrowdStrike’s (CRWD) Price Target to $550, Maintains Buy Rating
The rating was issued in anticipation of the company's fiscal Q1 2026 results on June 3, which the analyst expects to show strong growth, suggesting a return to growth in net ...
JPMorgan Reiterates ‘Overweight’ Rating on Pegasystems (PEGA)
On June 3, analysts at JPMorgan reiterated an ‘Overweight’ rating on Pegasystems Inc. (NASDAQ:PEGA) and maintained a $101 price target.
Pega Expands Blueprint AI to Accelerate Digital Transformation
On June 2, Pegasystems Inc.
Benchmark Maintains Buy Rating on Parsons (PNS) Despite Softer Revenue Guidance
Parsons Corporation (NYSE:PSN) recently revised its 2025 revenue guidance from $7 billion to $7.5 billion to $6.45 billion to $6.65 billion.
Morgan Stanley Maintains Hold Rating on Kymera Therapeutics (KYMR), Keeps PT
On June 2, analyst Vikram Purohit from Morgan Stanley maintained a Hold rating on Kymera Therapeutics, Inc. (NASDAQ:KYMR) with a price target of $49.
Jefferies Reiterates Hold Rating on Fiserv (FI), Keeps PT
On June 2, Jefferies analysts maintained a ‘Hold’ rating on Fiserv, Inc. (NYSE:FI) and kept the $165 price target.
BofA Securities Reiterates Buy Rating on Alphabet, Keeps PT
On June 2, BofA Securities analysts reiterated a ‘Buy’ rating and a $200 price target on Alphabet Inc. (NASDAQ:GOOGL).
Paramount (PARA) Expands Board Amid Skydance Merger Challenges
On June 2, Paramount Global (NASDAQ:PARA) confirmed the appointment of three new directors to boost its board strength to seven.
Morgan Stanley Stays Bearish on FedEx Ahead of Q4 Results
On Monday, June 2, Morgan Stanley analyst Ravi Shanker reiterated a Sell rating on FedEx Corp. (NYSE:FDX), maintaining his $200 price target.
BofA Remains Optimistic on Warner Bros. Discovery’s (WBD) Improved Strategic Flexibility
While the company’s stock has underperformed since the merger of Discovery and WarnerMedia in early 2022, Ehrlich believes Warner Bros.
Truist initiates Toast (TOST) with a Buy Rating and $48 Price Target
On June 2, Truist Securities analyst Matthew Coad initiated coverage on Toast Inc.
Zscaler’s (ZS) Growth Momentum Intact, Says Robert Baird
On June 2, Shrenik Kothari of Robert W. Baird reiterated his Buy rating on Zscaler Inc. (NASDAQ:ZS) with an unchanged price target of $315.
Alnylam Pharmaceuticals (ALNY) Price Target Raised to $500 by H.C. Wainwright
On June 2, H.C. Wainwright’s Patrick Trucchio reiterated his Buy rating on Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) and raised his price target from $400 to $500.
Needham Reaffirms Bullish View on Applied Digital (APLD) Following Landmark Ellendale Lease
On Monday, June 2, Needham’s John Todaro reaffirmed his Buy rating on Applied Digital Corporation (NASDAQ:APLD), keeping the price target unchanged at $10.
Morgan Stanley Lifts Grab (GRAB) Price Target, Maintains Buy Rating
On June 2, Morgan Stanley’s Divya Gangahar Kothiyal reiterated a Buy rating on Grab Holdings Limited (NASDAQ:GRAB) while revising the price target upward from $5.20 to $5.65...
Morgan Stanley Resumes Sanofi (SNY) Coverage, Assigns Equal Weight Rating
On June 2, Morgan Stanley analyst Sarita Kapila resumed coverage of Sanofi (NASDAQ:SNY), assigning an Equal Weight rating and setting a $56 price target.
Truist Begins Coverage of Fiserv (FI) with Buy Rating
On June 2, Truist Securities initiated coverage of Fiserv, Inc.
Truist Begins Coverage of Block (XYZ) with Sell Rating
On June 2, Truist Securities initiated coverage of Block, Inc.
Truist Begins Coverage of Sofi (SOFI) with Hold Rating
On June 2, Truist Securities initiated coverage of SoFi Technologies, Inc.
Wells Fargo Trims ConAgra (CAG) Price Target, Maintains Equal Weight Rating
On June 2, Wells Fargo reduced its price target on ConAgra Brands, Inc.
Morgan Stanley Trims Regeneron (REGN) Price Target, Maintains Overweight Rating
Morgan Stanley has lowered its price target on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) to $755 from $958, while maintaining an Overweight rating on the stock.
Truist Begins Coverage of Visa (V) with Buy Rating
On June 2, Truist Securities initiated coverage of Visa Inc. (NYSE:V) with a Buy rating and a $400 price target, citing strong fundamentals and a resilient long-term outlook.
Truist Raises Five Below (FIVE) Price Target, Maintains Hold Rating
On June 2, Truist Securities increased its price target on Five Below, Inc.
Truist Begins Coverage of Global Payments (GPN) with Hold Rating
On June 2, Truist initiated coverage of Global Payments Inc.
Truist Raises JP Morgan (JPM) Price Target, Maintains Hold Rating
Truist Securities lifted its price target on JPMorgan Chase & Co. (NYSE:JPM), on June 2, to $280 from $270, maintaining a Hold rating on the stock.
RBC Capital Starts Coverage of Reddit (RDDT) With Sector Perform Rating
On Monday, June 2, RBC Capital initiated coverage of Reddit, Inc. (NYSE:RDDT), assigning a “Sector Perform” rating and a $125 price target.
Citi Raises Kymera (KYMR) Price Target After Positive Drug Data, Keeps Buy Rating
On Monday, June 2, Citi analysts increased the price target on Kymera Therapeutics, Inc. (NASDAQ:KYMR) from $52 to $60 and kept a “Buy” rating.
Needham Lifts Taysha Gene Therapies (TSHA) PT to $8, Cites Positive Clinical Data
On June 2, Needham raised its price target for Taysha Gene Therapies Inc. (NASDAQ:TSHA) to $8 from $6, while maintaining a Buy rating on the stock.
Roth Capital Elevates Applied Digital (APLD) PT to $17.50 Following CoreWeave Lease Deal
On Tuesday, Roth Capital increased its price target for Applied Digital Corporation (NASDAQ:APLD) to $17.50 from $8.50, while keeping a Buy rating on the shares.
Oppenheimer Boosts Trevi Therapeutics (TRVI) PT to $23, Cites Positive Haduvio Trial Results
On Tuesday, Oppenheimer increased its price target for Trevi Therapeutics Inc. (NASDAQ:TRVI) to $23 from $20, while maintaining an Outperform rating.
BMO Capital Lifts Samsara (IOT) PT to $54 Ahead of Q1 Earnings Report
On June 2, BMO Capital increased its price target for Samsara Inc. (NYSE:IOT) to $54 from $48, while maintaining an Outperform rating on the stock.
BofA Upgrades Kymera Therapeutics (KYMR) to Buy, Lifts PT to $51
On June 2, Kymera Therapeutics Inc.
Accenture to Acquire SIPAL’s Integrated Product Support Business in Italy
On Tuesday, Accenture (NYSE:ACN) reached an agreement to acquire the Integrated Product Support/IPS business of SIPAL in Italy.
Hedge Fund Resource Center
